Search results
10 clinical trials to watch in the second half of 2024
BioPharma Dive· 2 days agoStudy results are expected for two closely watched obesity drugs, while key tests await for a...
PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
BioPharma Dive· 5 days agoEuropean drug regulators voted for a third time not to renew the approval of Translarna. Elsewhere,...